Search - tctmd.com

Displaying 1 - 20 of 23

Sort: Relevancy | Date

News Conference News EuroPCR 2024

Solid 2-Year Data With ‘Unlocking’ Coronary Stent: BIOADAPTOR RCT

Michael O'Riordan

May 28, 2024

$Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC$

News Conference News ACC 2024

Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC

Michael O'Riordan

April 08, 2024

News Industry News

Robocath successfully completes first robotic coronary angioplasties in Belgium

May 04, 2021

News Conference News EuroPCR 2020

DynamX Bioadaptor Provides Promising Preliminary Results for De Novo Coronary Lesions

Todd Neale

June 30, 2020

News Conference News EuroPCR 2018

New Bioresorbable Scaffold, Magmaris, Delivers Positive Early Outcomes

Michael O'Riordan

May 25, 2018

News Features EuroPCR 2017

Seven Next-Generation Bioresorbable Scaffolds Show Promise but Face Major Hurdles

Yael L. Maxwell

June 01, 2017

News Conference News TCT 2014

Novel Biodegradable Polymer DES Shows Efficacy, Long-term Safety

September 15, 2014

News Industry News

Elixir Medical Announces Schedule of Programs for TCT 2014

September 08, 2014

News Industry News

Successful Live Case Demonstration of Elixir Medical’s CE Mark-Approved Fully Bioresorbable DESolve® 100 Novolimus Eluting Coronary Scaffold System at EuroPCR

May 21, 2014

News Industry News

Elixir Medical Corporation to Showcase a Live Case Demonstration of the Breakthrough Fully Bioresorbable DESolve® 100 Novolimus Eluting Coronary Scaffold System at EuroPCR

May 14, 2014

News Industry News

Elixir Medical Receives CE Mark Approval for the Breakthrough Fully Bioresorbable DESolve® 100 Novolimus Eluting Coronary Scaffold System

May 13, 2014

News Industry News

InspireMD Announces First Patient Enrolled in U.S. Registration Trial for MGuard™ Prime EPS

July 29, 2013

News Industry News

Elixir Medical Corporation to Announce 6-month Results of the DESolve Fully Bioresorbable Coronary Scaffold System Pivotal Trial at Late Breaking Trial Session of EuroPCR

May 01, 2013

News Daily News

APPOSITION II Published: Self-Expanding Stent Performs Well in STEMI Patients

December 17, 2012

News Daily News

APPOSITION II Publicado: El Stent Auto Expandible Funciona Bien en Pacientes STEMI

December 17, 2012

News Industry News

Elixir Medical Announces Enrollment Completion of the DESolve Nx Pivotal Trial for Fully Bioresorbable Coronary Scaffold System

October 25, 2012

News Conference News EuroPCR 2012

Strong Showing for Bioabsorbable-Scaffold DES

Caitlin E. Cox

May 16, 2012

News Industry News

One-Year EVOLVE Trial Clinical Results Confirm Comparable Safety And Effectiveness Data Of The Boston Scientific SYNERGY™ Stent Versus PROMUS Element™ Platinum Chromium Stent

May 15, 2012

News Daily News

EVOLVE Published: Bioabsorbable EES Matches Permanent-Polymer Version

February 21, 2012

News Industry News

Elixir Medical Announces DESolve Nx International Pivotal Trial Initiation for Fully Bioresorbable Coronary Scaffold System

November 10, 2011

Advertisement

Solid 2-Year Data With ‘Unlocking’ Coronary Stent: BIOADAPTOR RCT

Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC

Robocath successfully completes first robotic coronary angioplasties in Belgium

DynamX Bioadaptor Provides Promising Preliminary Results for De Novo Coronary Lesions

New Bioresorbable Scaffold, Magmaris, Delivers Positive Early Outcomes

Seven Next-Generation Bioresorbable Scaffolds Show Promise but Face Major Hurdles

Novel Biodegradable Polymer DES Shows Efficacy, Long-term Safety

Elixir Medical Announces Schedule of Programs for TCT 2014

Successful Live Case Demonstration of Elixir Medical’s CE Mark-Approved Fully Bioresorbable DESolve® 100 Novolimus Eluting Coronary Scaffold System at EuroPCR

Elixir Medical Corporation to Showcase a Live Case Demonstration of the Breakthrough Fully Bioresorbable DESolve® 100 Novolimus Eluting Coronary Scaffold System at EuroPCR

Elixir Medical Receives CE Mark Approval for the Breakthrough Fully Bioresorbable DESolve® 100 Novolimus Eluting Coronary Scaffold System

InspireMD Announces First Patient Enrolled in U.S. Registration Trial for MGuard™ Prime EPS

Elixir Medical Corporation to Announce 6-month Results of the DESolve Fully Bioresorbable Coronary Scaffold System Pivotal Trial at Late Breaking Trial Session of EuroPCR

APPOSITION II Published: Self-Expanding Stent Performs Well in STEMI Patients

APPOSITION II Publicado: El Stent Auto Expandible Funciona Bien en Pacientes STEMI

Elixir Medical Announces Enrollment Completion of the DESolve Nx Pivotal Trial for Fully Bioresorbable Coronary Scaffold System

Strong Showing for Bioabsorbable-Scaffold DES

One-Year EVOLVE Trial Clinical Results Confirm Comparable Safety And Effectiveness Data Of The Boston Scientific SYNERGY™ Stent Versus PROMUS Element™ Platinum Chromium Stent

EVOLVE Published: Bioabsorbable EES Matches Permanent-Polymer Version

Elixir Medical Announces DESolve Nx International Pivotal Trial Initiation for Fully Bioresorbable Coronary Scaffold System

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content